Drug details
Cassipa (buprenorphine and naloxone sublingual film)
type of Analgesics, Opioid Partial Agonist, Opioid Antagonists
Cassipa (buprenorphine and naloxone) contains a partial-opioid agonist and an opioid antagonist and is indicated for the maintenance treatment of opioid dependence. Cassipa should be used as part of a complete treatment plan to include counseling and psychological support.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- upper stomach pain,
- loss of appetite,
- dark urine,
- vomiting,
- diarrhea,
- fever,
- lightheadedness,
- confusion,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- dizziness,
- blurred vision,
- sweating,
- agitation,
- shivering,
- runny nose,
- slurred speech,
- hallucinations,
- twitching,
- fast heart rate,
- weak or shallow breathing,
- loss of coordination,
- blue colored lips,
- muscle stiffness,
- extreme weakness,
- slow breathing with long pauses,
- breathing that stops during sleep,
- difficulty to arouse,
- worsening tiredness or weakness,
- goose bumps,
- increased sweating,
- feeling hot or cold,
- watery eyes, and
- muscle pain
The following drugs are related to Cassipa, either as a replacement or used together:
- Bunavail (buprenorphine and naloxone buccal film)
- Zubsolv (buprenorphine and naloxone sublingual tablets)
- Suboxone (buprenorphine hcl and naloxone hcl)
- Probuphine (buprenorphine implant)
- Dolophine (methadone tablets)
- Methadone Hydrochloride Injection (methadone hydrochloride injection)
- Vivitrol (naltrexone xr inj)